Director Laurence Hicks resigns from Arch Therapeutics board effective August 28, 2024

Arch Therapeutics, Inc.

Laurence Hicks resigned as Board member on August 28, 2024, effective immediately.
No disagreements of any kind exist between Mr. Hicks and the company regarding his resignation.
The filing does not announce a replacement for the departing director.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Laurence Hicks

director

Arch Therapeutics, Inc.

Effective: 2024-08-28
Filed: August 30, 2024, 7:59 PM ET

On August 28, 2024, Laurence Hicks notified the board of directors (the “Board”) of Arch Therapeutics, Inc. (the “Company”) that he will resign as a member of the Board effective August 28, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Laurence Hicks resigned as director at Arch Therapeutics, Inc..

Action: resigned
Role: director

Exact text from the filing

On August 28, 2024, Laurence Hicks notified the board of directors (the “Board”) of Arch Therapeutics, Inc. (the “Company”) that he will resign as a member of the Board effective August 28, 2024.

View on SEC.gov

Source: SEC EDGAR

accession 0001493152-24-034600

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.